Inloggen
Inloggen
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Registreer
Of aanmelden met
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     

ALNYLAM PHARMACEUTICALS, INC.

(ALNY)
  Rapport
Vertraagde tijd Nasdaq  -  22:00 02-12-2022
234.40 USD   +6.42%
30/11Transcript : Alnylam Pharmaceuticals, Inc. Presents at Piper Sandler 34th Annual Healthcare Conference, Nov-30-2022 09:30 AM
CI
29/11Transcript : Alnylam Pharmaceuticals, Inc. Presents at 5th Annual Evercore ISI HealthCONx Conference 2022, Nov-29-2022 01:50 PM
CI
16/11Transcript : Alnylam Pharmaceuticals, Inc. Presents at Stifel 2022 Healthcare Conference, Nov-16-2022 01:15 PM
CI
OverzichtKoersenGrafiekenNieuwsRatingsAgendaOndernemingFinanciŽnConsensusHerzieningenBeursproductenFonds 
 OverzichtAl het nieuwsAanbevelingen van analistenAndere talenPersberichtenOfficiŽle publicatiesSectornieuws
Nieuws over ALNYLAM PHARMACEUTICALS, INC.
30/11Transcript : Alnylam Pharmaceuticals, Inc. Presents at Piper Sandler 34th Ann..
CI
29/11Transcript : Alnylam Pharmaceuticals, Inc. Presents at 5th Annual Evercore IS..
CI
16/11Transcript : Alnylam Pharmaceuticals, Inc. Presents at Stifel 2022 Healthcare..
CI
16/11Transcript : Alnylam Pharmaceuticals, Inc. Presents at 13th Annual Jefferies ..
CI
07/11Alnylam Pharmaceuticals, Inc. : SVB Securities LLC herhaal..
MM
02/11Alnylam Pharmaceuticals, Inc. : HC Wainwright handhaaft ko..
MM
01/11Transcript : Alnylam Pharmaceuticals, Inc. - Special Call
CI
28/10Alnylam Pharmaceuticals, Inc. : Morgan Stanley is Neutraal..
MM
28/10Alnylam Pharmaceuticals, Inc. : Goldman Sachs ontvangt een..
MM
28/10Alnylam Pharmaceuticals, Inc. : Berenberg Bank handhaaft h..
MM
27/10Alnylam Pharmaceuticals stopt late fase onderzoek naar behandeling voor oogaandoeningen
MT
27/10Alnylam Pharmaceuticals derde kwartaal minder verlies, meer inkomsten
MT
27/10Transcript : Alnylam Pharmaceuticals, Inc., Q3 2022 Earnings Call, Oct 27, 20..
CI
27/10Alnylam Pharmaceuticals, Inc. Rapporteert winstresultaten voor het derde kwartaal en de..
CI
27/10Alnylam Pharmaceuticals, Inc. Herziet de winstverwachting voor het volledige jaar 2022
CI
24/10Alnylam Pharmaceuticals, Inc. : JPMorgan Chase blijft neut..
MM
21/10Transcript : Alnylam Pharmaceuticals, Inc. - Special Call
CI
Al het nieuws
Nieuws in andere talen op ALNYLAM PHARMACEUTICALS, INC.
02/12Alnylam Ranks 1 on Boston Globe's Top Places to Work List for 2022
01/12Alnylam Ranks #1 on Boston Globe's Top Places to Work List for 2022
23/11Insider Sell: Alnylam Pharmaceuticals
09/11Alnylam to Webcast Presentations at Upcoming November Investor Conferences
27/10Alnylam Pharmaceuticals Halts Late-Stage Trial on Eye Disorder Treatment
27/10Alnylam Recognized by Science Magazine as Top Employer for Fourth Consecutive Year
27/10Alnylam Pharmaceuticals Q3 Non-GAAP Loss Narrows, Revenue Rises
27/10ALNYLAM PHARMACEUTICALS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDIT..
27/10Alnylam Pharmaceuticals, Inc. Reports Earnings Results for the Third Quarter and Nine M..
27/10Alnylam : Q3 Earnings Snapshot
Meer nieuws
Analistenadviezen over ALNYLAM PHARMACEUTICALS, INC.
07/11Alnylam Pharmaceuticals, Inc. : SVB Securities LLC herhaal..
MM
02/11Alnylam Pharmaceuticals, Inc. : HC Wainwright handhaaft ko..
MM
28/10Alnylam Pharmaceuticals, Inc. : Morgan Stanley is Neutraal..
MM
28/10Alnylam Pharmaceuticals, Inc. : Goldman Sachs ontvangt een..
MM
28/10Alnylam Pharmaceuticals, Inc. : Berenberg Bank handhaaft h..
MM
Meer adviezen
Bedrijfsnieuws
02/12Alnylam Ranks 1 on Boston Globe's Top Places to Work List for 2022
AQ
01/12Alnylam Ranks #1 on Boston Globe's Top Places to Work List for 2022
BU
09/11Alnylam to Webcast Presentations at Upcoming November Investor Conferences
BU
27/10Alnylam Recognized by Science Magazine as Top Employer for Fourth Consecutive Year
BU
27/10ALNYLAM PHARMACEUTICALS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDIT..
AQ
Meer persberichten
Volgende evenement op ALNYLAM PHARMACEUTICALS, INC.
15/12/22R & D Day